Tissue Regenix Group plc (AIM:TRX)
London
· Delayed Price · Currency is GBP · Price in GBX 29.00
+1.00 (3.45%)
Aug 15, 2025, 4:35 PM GMT+1
Tissue Regenix Group Market Cap
Tissue Regenix Group has a market cap or net worth of 20.66 million as of August 15, 2025. Its market cap has decreased by -53.97% in one year.
Market Cap
20.66M
Enterprise Value
26.91M
Revenue
22.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.00
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has decreased from 41.00M to 20.66M, a decrease of -49.62%. That is a compound annual growth rate of -4.43%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.46B |
| GSK plc | 57.85B |
| Haleon | 32.21B |
| Smith & Nephew | 11.82B |
| ConvaTec Group | 4.64B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 2.11B |
| HUTCHMED (China) | 1.92B |